donanemab · Medicine question

What does the product information state about incompatibilities for Kisunla (donanemab) 350 mg concentrate for solution for infusion?

Name: What does the product information state about incompatibilities for Kisunla (donanemab) 350 mg concentrate for solution for infusion?
Published: 2026-11-08T13:46:44.461Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

The product information for Kisunla (donanemab) 350 mg concentrate for solution for infusion states “Not applicable” under incompatibilities.

Sources for this answer

Kisunla 350 mg concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §6.2 Incompatibilities · Version 3Document updated 24 March 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about donanemab